Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05934084 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Feb 1, 2026 → Feb 1, 2027
See other at-risk trials from Fondazione Italiana Linfomi - ETS

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Feb 1, 2026 to Feb 1, 2027
    • Study completion pushed from Feb 1, 2026 to Feb 1, 2028
    • Study sites revised (40)
    v8
  2. Site contacts updated at 1 of 40 sitesv7
  3. Site details revised at 15 of 40 sitesv6
  4. Site details revised at 40 of 40 sitesv5
  5. Site details revised at 40 of 40 sitesv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2024 to Feb 26, 2024
    • Site details revised at 40 of 40 sites
    v3
  2. Start date: Aug 1, 2023 to Jan 1, 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective randomized open-label, multicenter, 2-arm study to assess the role of healthy LifeStyle implemented Survivorship Care Plan (LS-SCP) in modifying the Quality of Life (QoL) in a population of long-term lymphoma survivors (in remission for a minimum 3 years since the last treatment and a maximum of 10 years).
Trial Details
NCT Number NCT05934084
Lead Sponsor Fondazione Italiana Linfomi - ETS
Conditions
(from sponsor)		 Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Related terms Lymphoma, Large B-Cell, Diffuse, Motor Activity
Enrollment 552 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov